Skip to main content

Animations

MJFF Publications

5501 - 5510 of 8436 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • Summary Details
    OPEN
    Title: miR-34a as hub of T cell regulation networks
    Journal Name: Journal for ImmunoTherapy of Cancer
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40425-019-0670-5
    Citation Count: 45
  • Summary Details
    RESTRICTED
    Title: Hallucinations, somatic‐functional disorders of PD‐DLB as expressions of thalamic dysfunction
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27781
    Citation Count: 55
  • Summary Details
    RESTRICTED
    Title: Highly sensitive HPLC-MS/MS assay for the quantitation of ondansetron in rat plasma and rat brain tissue homogenate following administration of a very low subcutaneous dose
    Journal Name: Journal of Pharmaceutical and Biomedical Analysis
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jpba.2019.07.014
    Best OA location URL:
    Citation Count: 11
  • Summary Details
    OPEN
    Title: The value of cerebrospinal fluid α‐synuclein and the tau/α‐synuclein ratio for diagnosis of neurodegenerative disorders with Lewy pathology
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1111/ene.14032
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Genetic risk of Parkinson disease and progression:
    Journal Name: Neurology Genetics
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/nxg.0000000000000348
    Citation Count: 135
  • Summary Details
    OPEN
    Title: Measuring Parkinson's disease over time: The real‐world within‐subject reliability of the MDS‐UPDRS
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.27790
    Citation Count: 146
  • Summary Details
    OPEN
    Title: The dynamic switch mechanism that leads to activation of LRRK2 is embedded in the DFGψ motif in the kinase domain
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.1900289116
    Citation Count: 73
  • Summary Details
    RESTRICTED
    Title: Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.07.010
    Best OA location URL:
    Citation Count: 28
  • Summary Details
    RESTRICTED
    Title: Spreading of alpha‐synuclein – relevant or epiphenomenon?
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/jnc.14779
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Progressive brain atrophy in Parkinson's disease patients who convert to mild cognitive impairment
    Journal Name: CNS Neuroscience & Therapeutics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/cns.13188
    Citation Count: 39
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.